TRS(SZ:002567)2019-10-27 16:00Financial Performance - Net profit attributable to shareholders was ¥84,658,649.31, representing a significant increase of 49.58% year-on-year[9]. - Operating revenue for the period was ¥4,042,726,794.73, reflecting a decrease of 4.69% compared to the same period last year[9]. - Basic earnings per share were ¥0.1012, an increase of 49.26% compared to the same period last year[9]. - The company's total comprehensive income for the period was not disclosed in the provided documents, but the focus remains on asset management and equity growth strategies[120]. - Total operating revenue for the current period is ¥308,480,766.67, a decrease of 29% compared to ¥433,775,277.13 in the previous period[70]. - Net profit for the current period reached ¥111,554,788.71, representing an increase of 44.4% from ¥77,261,671.37 in the previous period[62]. - The total profit for the current period is ¥223,895,816.27, slightly up from ¥223,177,220.73 in the previous period, reflecting a marginal increase of about 0.3%[82]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥7,099,847,455.67, an increase of 8.71% compared to the end of the previous year[9]. - Total current assets increased to ¥2,724,519,900.69 as of September 30, 2019, compared to ¥2,468,370,198.80 as of December 31, 2018, representing a growth of approximately 10.4%[42]. - Total liabilities increased to ¥3,116,499,615.17 from ¥2,578,242,367.37, representing a growth of about 20.9%[45]. - The company's equity attributable to shareholders rose to ¥3,454,096,409.24 from ¥3,407,291,794.46, showing an increase of approximately 1.4%[48]. - The company reported accounts receivable of CNY 1,888,766.70 and other receivables of CNY 1,848,039,142.47[118]. - The company has a total of CNY 368,000,000.00 in long-term borrowings, indicating its financing structure[111]. Cash Flow - The net cash flow from operating activities was negative at -¥11,860,411.03, a decline of 113.69% year-on-year[9]. - Cash and cash equivalents increased by 30.02% compared to the beginning of the period, mainly due to an increase of 200 million in bank deposits[24]. - Operating cash inflow totaled CNY 11,283,135,414.16, an increase from CNY 10,967,585,640.85 in the previous period[95]. - Net cash flow from operating activities was CNY 126,010,394.81, down from CNY 224,488,262.35 in the previous period[95]. - Financing cash inflow totaled CNY 1,487,553,117.00, significantly higher than CNY 720,080,000.00 in the previous period[98]. - Net cash flow from financing activities improved to CNY 325,193,517.89 from CNY 14,270,047.57[98]. Research and Development - R&D expenses increased by 53.08% year-on-year, mainly due to increased R&D investments by high-tech subsidiaries[25]. - Research and development expenses increased to ¥56,927,736.85, up from ¥34,381,095.58, reflecting a growth of 65.7%[59]. - Research and development expenses increased to ¥22,132,538.82, up from ¥16,144,812.58, representing a growth of approximately 37%[70]. - Research and development expenses increased to ¥71,813,630.96 from ¥56,439,270.56, reflecting a rise of about 27%[86]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 60,698[13]. - The largest shareholder, Hunan Tangrenshen Holdings Investment Co., Ltd., held 19.96% of the shares[13]. Other Financial Metrics - The weighted average return on net assets was 2.44%, an increase of 0.82% compared to the previous year[9]. - The company reported a government subsidy of ¥9,084,824.57 during the period[9]. - Non-operating income and expenses included a loss from the disposal of non-current assets amounting to -¥26,518,259.37[9]. - The company reported a significant increase in other payables, which rose to ¥935,820,636.43 from ¥644,906,422.08, an increase of 45.0%[55].